Abstract
The translation of fluorescence molecular imaging is challenged by the “first-of-its-kind” drug (imaging agent) and device combination. Yet upon deploying principles of validation, standardization, and calibration, the translational process can be accelerated. Examples are highlighted.
© 2013 Optical Society of America
PDF ArticleMore Like This
P. Beatriz Garcia-Allende, Jürgen Glatz, Jolien Tjalma, Anton Terwisscha van Scheltinga, Jan Jacob Koorstra, Jan H. Kleibeuker, Go van Dam, Wouter B. Nagengast, and Vasilis Ntziachristos
MW5C.6 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2013
John C. Rasmussen and Eva M. Sevick-Muraca
AM1P.1 CLEO: Applications and Technology (CLEO:A&T) 2014
Ali Azhdarinia, Sukhen C. Ghosh, Kenneth L. Pinkston, Mary A. Hall, Nathaniel Wilganowski, Holly Robinson, Otis Hall, Barrett R. Harvey, and Eva M. Sevick-Muraca
JM3A.3 Bio-Optics: Design and Application (BODA) 2013